Publicação

Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal

Ver documento

Detalhes bibliográficos
Resumo:BACKGROUND: Onchocerca lupi and Cercopithifilaria spp. are vector-borne filarioids of dogs, which harbour skin microfilariae (mfs), the former being of zoonotic concern. Proper treatment studies using compounds with microfilaricidal activity have not been performed. Therefore, this study aimed to assess the efficacy of a commercially available spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of O. lupi or Cercopithifilaria spp. skin-dwelling mfs in naturally infected dogs. METHODS: Privately owned dogs (n = 393) from southern Portugal were sampled via skin biopsies to identify and count mfs in 20 µl of skin sediment. A total of 22 mfs-positive dogs were allocated to treatment group (n = 11; G1) or left untreated as a control (n = 11; G2). As a pilot investigation to test the treatment efficacy, five dogs assigned to G1 were treated four times at monthly intervals with moxidectin 2.5%/imidacloprid 10% spot-on formulation on SDs 0, 28 (± 2), 56 (± 2), and 84 (± 2). Based on the negative results for both O. lupi and/or Cercopithifilaria spp. mfs of dogs in the pilot study from SD28 onwards, the remaining six dogs in G1 were treated at SD0 and assessed only at SD28. RESULTS: Of the 393 animals sampled, 78 (19.8%) scored positive for skin-dwelling mfs. At the pilot investigation, a mean number of 19.6 mfs for O. lupi was recorded among five infected dogs whereas no mfs were detected at SD28. At SD0, the mean number of Cercopithifilaria spp. larvae was 12.6 for G1 and 8.7 for G2. The mean number of mfs for G2 was 20.09. CONCLUSIONS: Results herein obtained suggest that a single treatment with moxidectin 2.5%/imidacloprid 10% spot-on formulation is efficacious against skin-dwelling mfs in dogs. The microfilaricidal effect of moxidectin could also be useful in reducing the risk of O. lupi infection for humans.
Autores principais:Otranto, Domenico
Outros Autores:Colella, Vito; Bezerra-santos, Marcos Antônio; Mendoza-roldan, Jairo Alfonso; Cavalera, Maria Alfonsa; Pereira, André; Schaper, Roland; Maia, Carla
Assunto:Infectious Diseases General Veterinary SDG 3 - Good Health and Well-being SDG 12 - Responsible Consumption and Production SDG 15 - Life on Land
Ano:2021
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade Nova de Lisboa
Idioma:inglês
Origem:Repositório Institucional da UNL
_version_ 1879446202335887360
author Otranto, Domenico
author2 Colella, Vito
Bezerra-santos, Marcos Antônio
Mendoza-roldan, Jairo Alfonso
Cavalera, Maria Alfonsa
Pereira, André
Schaper, Roland
Maia, Carla
author2_role author
author
author
author
author
author
author
author_facet Otranto, Domenico
Colella, Vito
Bezerra-santos, Marcos Antônio
Mendoza-roldan, Jairo Alfonso
Cavalera, Maria Alfonsa
Pereira, André
Schaper, Roland
Maia, Carla
author_role author
contributor_name_str_mv Instituto de Higiene e Medicina Tropical (IHMT)
Global Health and Tropical Medicine (GHTM)
Vector borne diseases and pathogens (VBD)
BioMed Central (BMC)
RUN
country_str PT
creators_json_txt [{\"Person.name\":\"Otranto, Domenico\"},{\"Person.name\":\"Colella, Vito\"},{\"Person.name\":\"Bezerra-santos, Marcos Antônio\"},{\"Person.name\":\"Mendoza-roldan, Jairo Alfonso\"},{\"Person.name\":\"Cavalera, Maria Alfonsa\"},{\"Person.name\":\"Pereira, André\"},{\"Person.name\":\"Schaper, Roland\"},{\"Person.name\":\"Maia, Carla\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Instituto de Higiene e Medicina Tropical (IHMT)
Global Health and Tropical Medicine (GHTM)
Vector borne diseases and pathogens (VBD)
BioMed Central (BMC)
RUN
datacite.creators.creator.creatorName.fl_str_mv Otranto, Domenico
Colella, Vito
Bezerra-santos, Marcos Antônio
Mendoza-roldan, Jairo Alfonso
Cavalera, Maria Alfonsa
Pereira, André
Schaper, Roland
Maia, Carla
datacite.date.Accepted.fl_str_mv 2021-12-01T00:00:00Z
datacite.date.available.fl_str_mv 2021-04-30T22:44:43Z
datacite.date.embargoed.fl_str_mv 2021-04-30T22:44:43Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Infectious Diseases
General Veterinary
SDG 3 - Good Health and Well-being
SDG 12 - Responsible Consumption and Production
SDG 15 - Life on Land
datacite.titles.title.fl_str_mv Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal
dc.contributor.none.fl_str_mv Instituto de Higiene e Medicina Tropical (IHMT)
Global Health and Tropical Medicine (GHTM)
Vector borne diseases and pathogens (VBD)
BioMed Central (BMC)
RUN
dc.creator.none.fl_str_mv Otranto, Domenico
Colella, Vito
Bezerra-santos, Marcos Antônio
Mendoza-roldan, Jairo Alfonso
Cavalera, Maria Alfonsa
Pereira, André
Schaper, Roland
Maia, Carla
dc.date.Accepted.fl_str_mv 2021-12-01T00:00:00Z
dc.date.available.fl_str_mv 2021-04-30T22:44:43Z
dc.date.embargoed.fl_str_mv 2021-04-30T22:44:43Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10362/116525
dc.language.none.fl_str_mv eng
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv Infectious Diseases
General Veterinary
SDG 3 - Good Health and Well-being
SDG 12 - Responsible Consumption and Production
SDG 15 - Life on Land
dc.title.fl_str_mv Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description BACKGROUND: Onchocerca lupi and Cercopithifilaria spp. are vector-borne filarioids of dogs, which harbour skin microfilariae (mfs), the former being of zoonotic concern. Proper treatment studies using compounds with microfilaricidal activity have not been performed. Therefore, this study aimed to assess the efficacy of a commercially available spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of O. lupi or Cercopithifilaria spp. skin-dwelling mfs in naturally infected dogs. METHODS: Privately owned dogs (n = 393) from southern Portugal were sampled via skin biopsies to identify and count mfs in 20 µl of skin sediment. A total of 22 mfs-positive dogs were allocated to treatment group (n = 11; G1) or left untreated as a control (n = 11; G2). As a pilot investigation to test the treatment efficacy, five dogs assigned to G1 were treated four times at monthly intervals with moxidectin 2.5%/imidacloprid 10% spot-on formulation on SDs 0, 28 (± 2), 56 (± 2), and 84 (± 2). Based on the negative results for both O. lupi and/or Cercopithifilaria spp. mfs of dogs in the pilot study from SD28 onwards, the remaining six dogs in G1 were treated at SD0 and assessed only at SD28. RESULTS: Of the 393 animals sampled, 78 (19.8%) scored positive for skin-dwelling mfs. At the pilot investigation, a mean number of 19.6 mfs for O. lupi was recorded among five infected dogs whereas no mfs were detected at SD28. At SD0, the mean number of Cercopithifilaria spp. larvae was 12.6 for G1 and 8.7 for G2. The mean number of mfs for G2 was 20.09. CONCLUSIONS: Results herein obtained suggest that a single treatment with moxidectin 2.5%/imidacloprid 10% spot-on formulation is efficacious against skin-dwelling mfs in dogs. The microfilaricidal effect of moxidectin could also be useful in reducing the risk of O. lupi infection for humans.
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://run.unl.pt/bitstreams/8dce5a44-62de-4bd7-8702-1ec522992453/download
id run_b8d2b0835ee59679d13350201992a774
identifier.url.fl_str_mv http://hdl.handle.net/10362/116525
inst_facet_str urn:organizationAcronym:unl{{{_:::_}}}Universidade Nova de Lisboa
instacron_str unl
institution Universidade Nova de Lisboa
instname_str Universidade Nova de Lisboa
language eng
network_acronym_str run
network_name_str Repositório Institucional da UNL
oai_identifier_str oai:run.unl.pt:10362/116525
organization_str_mv urn:organizationAcronym:unl
person_str_mv Otranto, Domenico
Colella, Vito
Bezerra-santos, Marcos Antônio
Mendoza-roldan, Jairo Alfonso
Cavalera, Maria Alfonsa
Pereira, André
Schaper, Roland
Maia, Carla
publishDate 2021
repo_facet_str urn:repositoryAcronym:run{{{_:::_}}}Repositório Institucional da UNL
reponame_str Repositório Institucional da UNL
repository_id_str urn:repositoryAcronym:run
service_str_mv urn:repositoryAcronym:run
spelling engenBACKGROUND: Onchocerca lupi and Cercopithifilaria spp. are vector-borne filarioids of dogs, which harbour skin microfilariae (mfs), the former being of zoonotic concern. Proper treatment studies using compounds with microfilaricidal activity have not been performed. Therefore, this study aimed to assess the efficacy of a commercially available spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of O. lupi or Cercopithifilaria spp. skin-dwelling mfs in naturally infected dogs. METHODS: Privately owned dogs (n = 393) from southern Portugal were sampled via skin biopsies to identify and count mfs in 20 µl of skin sediment. A total of 22 mfs-positive dogs were allocated to treatment group (n = 11; G1) or left untreated as a control (n = 11; G2). As a pilot investigation to test the treatment efficacy, five dogs assigned to G1 were treated four times at monthly intervals with moxidectin 2.5%/imidacloprid 10% spot-on formulation on SDs 0, 28 (± 2), 56 (± 2), and 84 (± 2). Based on the negative results for both O. lupi and/or Cercopithifilaria spp. mfs of dogs in the pilot study from SD28 onwards, the remaining six dogs in G1 were treated at SD0 and assessed only at SD28. RESULTS: Of the 393 animals sampled, 78 (19.8%) scored positive for skin-dwelling mfs. At the pilot investigation, a mean number of 19.6 mfs for O. lupi was recorded among five infected dogs whereas no mfs were detected at SD28. At SD0, the mean number of Cercopithifilaria spp. larvae was 12.6 for G1 and 8.7 for G2. The mean number of mfs for G2 was 20.09. CONCLUSIONS: Results herein obtained suggest that a single treatment with moxidectin 2.5%/imidacloprid 10% spot-on formulation is efficacious against skin-dwelling mfs in dogs. The microfilaricidal effect of moxidectin could also be useful in reducing the risk of O. lupi infection for humans.application/pdfenEfficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from PortugalOtranto, DomenicoColella, VitoBezerra-santos, Marcos AntônioMendoza-roldan, Jairo AlfonsoCavalera, Maria AlfonsaPereira, AndréSchaper, RolandMaia, CarlaInstituto de Higiene e Medicina Tropical (IHMT)Global Health and Tropical Medicine (GHTM)Vector borne diseases and pathogens (VBD)BioMed Central (BMC)HostingInstitutionOrganizationalRUNe-mailmailto:run@unl.ptrun@unl.ptISSNIsPartOf1756-3305URNIsPartOfPURE: 29273873URNIsPartOfPURE UUID: 4ed3e026-641d-48d2-8719-750955d0f6b6URNIsPartOfcrossref: 10.1186/s13071-021-04704-7URNIsPartOfORCID: /0000-0002-2545-7686/work/92451640URNIsPartOfScopus: 85104297618DOIIsPartOf10.1186/s13071-021-04704-72021-04-30T22:44:43Z2021-12-012021-12-01T00:00:00ZHandlehttp://hdl.handle.net/10362/116525http://purl.org/coar/access_right/c_abf2open accessInfectious DiseasesGeneral VeterinarySDG 3 - Good Health and Well-beingSDG 12 - Responsible Consumption and ProductionSDG 15 - Life on Land1047861 bytesliteraturehttp://purl.org/coar/resource_type/c_6501journal articlehttp://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://run.unl.pt/bitstreams/8dce5a44-62de-4bd7-8702-1ec522992453/download
spellingShingle Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal
Otranto, Domenico
Infectious Diseases
General Veterinary
SDG 3 - Good Health and Well-being
SDG 12 - Responsible Consumption and Production
SDG 15 - Life on Land
status SINGLETON
subject.fl_str_mv Infectious Diseases
General Veterinary
SDG 3 - Good Health and Well-being
SDG 12 - Responsible Consumption and Production
SDG 15 - Life on Land
title Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal
title_full Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal
title_fullStr Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal
title_full_unstemmed Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal
title_short Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal
title_sort Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal
topic Infectious Diseases
General Veterinary
SDG 3 - Good Health and Well-being
SDG 12 - Responsible Consumption and Production
SDG 15 - Life on Land
topic_facet Infectious Diseases
General Veterinary
SDG 3 - Good Health and Well-being
SDG 12 - Responsible Consumption and Production
SDG 15 - Life on Land
url http://hdl.handle.net/10362/116525
visible 1

Atividades financiadas

Não foram encontrados projetos financiados.